The novel tetrahydrofuran derivative ANAVEX2-73 attenuated GSK-3β activation and Tau hyperphosphorylation in a nontransgenic Alzheimer’s disease model in mice.

Alzheimer’s Association International Conference, July 16-21, 2011, Paris, France

Valentine Lahmy, Susanna Malmstrom, Johann Meunier, Vanessa Villard, Alexandre Vamvakides and Tangui Maurice

View Poster

Share this: